269 related articles for article (PubMed ID: 25252941)
1. Single-cell analyses of regulatory network perturbations using enhancer-targeting TALEs suggest novel roles for PU.1 during haematopoietic specification.
Wilkinson AC; Kawata VK; Schütte J; Gao X; Antoniou S; Baumann C; Woodhouse S; Hannah R; Tanaka Y; Swiers G; Moignard V; Fisher J; Hidetoshi S; Tijssen MR; de Bruijn MF; Liu P; Göttgens B
Development; 2014 Oct; 141(20):4018-30. PubMed ID: 25252941
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.
Calero-Nieto FJ; Wood AD; Wilson NK; Kinston S; Landry JR; Göttgens B
Nucleic Acids Res; 2010 Oct; 38(19):6363-74. PubMed ID: 20525788
[TBL] [Abstract][Full Text] [Related]
3. PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.
Gupta P; Gurudutta GU; Saluja D; Tripathi RP
J Cell Mol Med; 2009; 13(11-12):4349-63. PubMed ID: 19382896
[TBL] [Abstract][Full Text] [Related]
4. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
5. PU.1/Spi-1 binds to the human TAL-1 silencer to mediate its activity.
Le Clech M; Chalhoub E; Dohet C; Roure V; Fichelson S; Moreau-Gachelin F; Mathieu D
J Mol Biol; 2006 Jan; 355(1):9-19. PubMed ID: 16298389
[TBL] [Abstract][Full Text] [Related]
6. The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis.
Burda P; Laslo P; Stopka T
Leukemia; 2010 Jul; 24(7):1249-57. PubMed ID: 20520638
[TBL] [Abstract][Full Text] [Related]
7. Subversion of T lineage commitment by PU.1 in a clonal cell line system.
Dionne CJ; Tse KY; Weiss AH; Franco CB; Wiest DL; Anderson MK; Rothenberg EV
Dev Biol; 2005 Apr; 280(2):448-66. PubMed ID: 15882585
[TBL] [Abstract][Full Text] [Related]
8. PU.1 and hematopoiesis: lessons learned from gene targeting experiments.
Simon MC
Semin Immunol; 1998 Apr; 10(2):111-8. PubMed ID: 9618756
[TBL] [Abstract][Full Text] [Related]
9. Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3.
Del Real MM; Rothenberg EV
Development; 2013 Mar; 140(6):1207-19. PubMed ID: 23444353
[TBL] [Abstract][Full Text] [Related]
10. PU.1 regulates the expression of the vav proto-oncogene.
Denkinger DJ; Lambrecht TQ; Cushman-Vokoun AM; Kawahara RS
J Cell Biochem; 2002; 84(4):772-83. PubMed ID: 11835402
[TBL] [Abstract][Full Text] [Related]
11. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
[TBL] [Abstract][Full Text] [Related]
12. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.
Meraro D; Gleit-Kielmanowicz M; Hauser H; Levi BZ
J Immunol; 2002 Jun; 168(12):6224-31. PubMed ID: 12055236
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development.
Wilson NK; Miranda-Saavedra D; Kinston S; Bonadies N; Foster SD; Calero-Nieto F; Dawson MA; Donaldson IJ; Dumon S; Frampton J; Janky R; Sun XH; Teichmann SA; Bannister AJ; Göttgens B
Blood; 2009 May; 113(22):5456-65. PubMed ID: 19346495
[TBL] [Abstract][Full Text] [Related]
14. Role of PU.1 in hematopoiesis.
Fisher RC; Scott EW
Stem Cells; 1998; 16(1):25-37. PubMed ID: 9474745
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional network control of normal and leukaemic haematopoiesis.
Sive JI; Göttgens B
Exp Cell Res; 2014 Dec; 329(2):255-64. PubMed ID: 25014893
[TBL] [Abstract][Full Text] [Related]
16. Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafish.
Rhodes J; Hagen A; Hsu K; Deng M; Liu TX; Look AT; Kanki JP
Dev Cell; 2005 Jan; 8(1):97-108. PubMed ID: 15621533
[TBL] [Abstract][Full Text] [Related]
17. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
Tondravi MM; McKercher SR; Anderson K; Erdmann JM; Quiroz M; Maki R; Teitelbaum SL
Nature; 1997 Mar; 386(6620):81-4. PubMed ID: 9052784
[TBL] [Abstract][Full Text] [Related]
18. Gfi1 expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.
Wilson NK; Timms RT; Kinston SJ; Cheng YH; Oram SH; Landry JR; Mullender J; Ottersbach K; Gottgens B
Mol Cell Biol; 2010 Aug; 30(15):3853-63. PubMed ID: 20516218
[TBL] [Abstract][Full Text] [Related]
19. Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis.
Giladi A; Paul F; Herzog Y; Lubling Y; Weiner A; Yofe I; Jaitin D; Cabezas-Wallscheid N; Dress R; Ginhoux F; Trumpp A; Tanay A; Amit I
Nat Cell Biol; 2018 Jul; 20(7):836-846. PubMed ID: 29915358
[TBL] [Abstract][Full Text] [Related]
20. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.
Mikkola HK; Klintman J; Yang H; Hock H; Schlaeger TM; Fujiwara Y; Orkin SH
Nature; 2003 Jan; 421(6922):547-51. PubMed ID: 12540851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
